FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2593209668> ?p ?o ?g. }

• W2593209668 endingPage "67" @default.
• W2593209668 startingPage "60" @default.
• W2593209668 abstract "OBJECTIVE Cavernous sinus hemangiomas (CSHs) are rare benign vascular tumors that arise from the dural venous sinuses lateral to the sella. Stereotactic radiosurgery (SRS) has emerged as a principal alternative to microresection for small- and medium-sized CSHs. Resection is a reasonable option for large (3–4 cm in diameter) and giant (> 4 cm in diameter) CSHs. However, management of giant CSHs remains a challenge for neurosurgeons because of the high rates of morbidity and even death that stem from uncontrollable and massive hemorrhage during surgery. The authors report here the results of their study on the use of hypofractionated SRS (H-SRS) to treat giant CSH. METHODS Between January 2008 and April 2014, 31 patients with a giant CSH (tumor volume > 40 cm 3 , > 4 cm in diameter) treated using CyberKnife radiosurgery were enrolled in a cohort study. Clinical status and targeted reduction of tumor volume were evaluated by means of serial MRI. The diagnosis for 27 patients was determined on the basis of typical imaging features. In 4 patients, the diagnosis of CSH was confirmed histopathologically. The median CSH volume was 64.4 cm 3 (range 40.9–145.3 cm 3 ). Three or 4 sessions of CyberKnife radiosurgery were used with a prescription dose based on the intent to cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways and brainstem. The median marginal dose to the tumor was 21 Gy (range 19.5–21 Gy) in 3 fractions for 11 patients and 22 Gy (range 18–22 Gy) in 4 fractions for 20 patients. RESULTS The median duration of follow-up was 30 months (range 6–78 months) for all patients. Follow-up MRI scans revealed a median tumor volume reduction of 88.1% (62.3%–99.4%) at last examination compared with the pretreatment volume. Ten patients developed new or aggravated temporary headache and 5 experienced vomiting during the treatment; these acute symptoms were relieved completely after steroid administration. Among the 30 patients with symptoms observed before treatment, 19 achieved complete symptomatic remission, and 11 had partial remission. One patient reported seizures, which were controlled after antiepileptic drug administration. No radiation-induced neurological deficits or delayed complications were reported during the follow-up period. CONCLUSIONS Hypofractionated SRS was an effective and safe modality for treating giant CSH. Considering the risks involved with microsurgery, it is possible that H-SRS might be able to serve as a definitive primary treatment option for giant CSH." @default.
• W2593209668 created "2017-03-16" @default.
• W2593209668 creator A5001786262 @default.
• W2593209668 creator A5006822602 @default.
• W2593209668 creator A5022662736 @default.
• W2593209668 creator A5023266885 @default.
• W2593209668 creator A5026098145 @default.
• W2593209668 creator A5029003093 @default.
• W2593209668 creator A5046534928 @default.
• W2593209668 creator A5051882120 @default.
• W2593209668 creator A5065207219 @default.
• W2593209668 creator A5091013824 @default.
• W2593209668 date "2018-01-01" @default.
• W2593209668 modified "2023-09-26" @default.
• W2593209668 title "Hypofractionated stereotactic radiosurgery: a new treatment strategy for giant cavernous sinus hemangiomas" @default.
• W2593209668 cites W1503145650 @default.
• W2593209668 cites W1548155623 @default.
• W2593209668 cites W1556604849 @default.
• W2593209668 cites W1569162685 @default.
• W2593209668 cites W1982805247 @default.
• W2593209668 cites W1983788253 @default.
• W2593209668 cites W1986119559 @default.
• W2593209668 cites W1991625499 @default.
• W2593209668 cites W1997539049 @default.
• W2593209668 cites W2022131209 @default.
• W2593209668 cites W2032700496 @default.
• W2593209668 cites W2032825101 @default.
• W2593209668 cites W2037936763 @default.
• W2593209668 cites W2044644774 @default.
• W2593209668 cites W2045470941 @default.
• W2593209668 cites W2061366772 @default.
• W2593209668 cites W2071003520 @default.
• W2593209668 cites W2073792567 @default.
• W2593209668 cites W2149213415 @default.
• W2593209668 cites W2149428854 @default.
• W2593209668 cites W2462776655 @default.
• W2593209668 cites W3150261240 @default.
• W2593209668 cites W4237254639 @default.
• W2593209668 cites W4241378982 @default.
• W2593209668 doi "https://doi.org/10.3171/2016.10.jns16693" @default.
• W2593209668 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28298046" @default.
• W2593209668 hasPublicationYear "2018" @default.
• W2593209668 type Work @default.
• W2593209668 sameAs 2593209668 @default.
• W2593209668 citedByCount "15" @default.
• W2593209668 countsByYear W25932096682018 @default.
• W2593209668 countsByYear W25932096682020 @default.
• W2593209668 countsByYear W25932096682021 @default.
• W2593209668 countsByYear W25932096682022 @default.
• W2593209668 countsByYear W25932096682023 @default.
• W2593209668 crossrefType "journal-article" @default.
• W2593209668 hasAuthorship W2593209668A5001786262 @default.
• W2593209668 hasAuthorship W2593209668A5006822602 @default.
• W2593209668 hasAuthorship W2593209668A5022662736 @default.
• W2593209668 hasAuthorship W2593209668A5023266885 @default.
• W2593209668 hasAuthorship W2593209668A5026098145 @default.
• W2593209668 hasAuthorship W2593209668A5029003093 @default.
• W2593209668 hasAuthorship W2593209668A5046534928 @default.
• W2593209668 hasAuthorship W2593209668A5051882120 @default.
• W2593209668 hasAuthorship W2593209668A5065207219 @default.
• W2593209668 hasAuthorship W2593209668A5091013824 @default.
• W2593209668 hasConcept C126838900 @default.
• W2593209668 hasConcept C141071460 @default.
• W2593209668 hasConcept C2776651944 @default.
• W2593209668 hasConcept C2776741419 @default.
• W2593209668 hasConcept C2780387249 @default.
• W2593209668 hasConcept C2989005 @default.
• W2593209668 hasConcept C509974204 @default.
• W2593209668 hasConcept C71924100 @default.
• W2593209668 hasConceptScore W2593209668C126838900 @default.
• W2593209668 hasConceptScore W2593209668C141071460 @default.
• W2593209668 hasConceptScore W2593209668C2776651944 @default.
• W2593209668 hasConceptScore W2593209668C2776741419 @default.
• W2593209668 hasConceptScore W2593209668C2780387249 @default.
• W2593209668 hasConceptScore W2593209668C2989005 @default.
• W2593209668 hasConceptScore W2593209668C509974204 @default.
• W2593209668 hasConceptScore W2593209668C71924100 @default.
• W2593209668 hasIssue "1" @default.
• W2593209668 hasLocation W25932096681 @default.
• W2593209668 hasLocation W25932096682 @default.
• W2593209668 hasOpenAccess W2593209668 @default.
• W2593209668 hasPrimaryLocation W25932096681 @default.
• W2593209668 hasRelatedWork W1970697270 @default.
• W2593209668 hasRelatedWork W2017956518 @default.
• W2593209668 hasRelatedWork W2053511483 @default.
• W2593209668 hasRelatedWork W2063122912 @default.
• W2593209668 hasRelatedWork W2560837950 @default.
• W2593209668 hasRelatedWork W2888000049 @default.
• W2593209668 hasRelatedWork W2953263120 @default.
• W2593209668 hasRelatedWork W3021421456 @default.
• W2593209668 hasRelatedWork W3029654687 @default.
• W2593209668 hasRelatedWork W3180744360 @default.
• W2593209668 hasVolume "128" @default.
• W2593209668 isParatext "false" @default.
• W2593209668 isRetracted "false" @default.
• W2593209668 magId "2593209668" @default.
• W2593209668 workType "article" @default.